EN
抗体药类似物
Research Grade Ocrelizumab
All
TD-HY257026_1.jpg
TD-HY257026_2.jpg
TD-HY257026_3.jpg
  • CatalogTD-HY257026
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • Synonyms2H7,PR-070769/PR070769/R-1594/RG-1594,CAS:637334-45-3
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Ocrelizumab


Catalog No. TD-HY257026
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG1-nd
Expression system Mammalian Cells
Clonality Monoclonal
Target B-lymphocyte surface antigen B1, Membrane-spanning 4-domains subfamily A member 1, MS4A1, Leukocyte surface antigen Leu-16, B-lymphocyte antigen CD20, Bp35, CD20
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P11836
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names 2H7,PR-070769/PR070769/R-1594/RG-1594,CAS:637334-45-3
Background Ocrelizumab (Ocrevus) is a humanized anti-CD20 monoclonal antibody. Ocrelizumab can induce B cell depletion and inhibit multiple sclerosis lesions in mice through antibody dependent cytotoxicity (ADCC).
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HY257026_1.jpg
SEC-HPLC
 
SEC-HPLC detection for Research Grade Ocrelizumab.
TD-HY257026_2.jpg
Bioactivity
 
Detects Human CD20/MS4A1 in indirect ELISAs.
TD-HY257026_3.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Ocrelizumab.